The growth and metastatic behavior of several human tumor lines grown in adult nude mice, nude mice pretreated with antiserum against asialo GM1 glycoprotein, and beige nude mice were studied. The cell lines were all injected s.c. and i.v. A human colon carcinoma line was also injected into the sple
Estrogen- and androgen-responsive growth of human ovarian adenocarcinoma heterotransplanted into nude mice
β Scribed by Masumi Sawada; Nobuyuki Terada; Akira Wada; Yoichi Mori; Masato Yamasaki; Tsuneo Saga; Keigo Endo
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 648 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
A new line of human serous cystadenocarcinoma of the ovary, designated OVA-5, has been established in athymic nude mice. A strong correlation was noted between tumor volume and plasma CAI25 levels in mice bearing O V A 4 tumor. Growth of the O V A 4 tumor in castrated male nude mice was accelerated by S.C. administration of estradiol-I7p and 5a-dihydrotestosterone but not by progesterone. Estradiol-I7p and 5a-dihydrotestosterone also accelerated the growth of the O V A 4 tumor heterotransplanted into rialoadenectomized castrated male nude mice. No remarkable change was observed in the histological appearances of the tumors between control groups and hormone-treated groups. Receptor assays revealed that the O V A 4 tumor had both estrogen and androgen receptors. Growth of the O V A 4 tumor is thus responsive to estrogen and androgen.
π SIMILAR VOLUMES
## BACKGROUND. In this study, we investigated whether dietary intervention could inhibit tumor growth of an androgen-sensitive human prostatic cancer. METHODS. LNCaP cells were transplanted subcutaneously in nude-mice. The animals were then put on different diets and tumor take, tumor growth and pr
The effects of the novel anti-estrogen EM-343 on the growth of 2 hormone-responsive human breast cancer tumors have been examined in athymic nude mice. At the low daily dose of 5 g, EM-343 administered subcutaneously for 6 months completely blocked the stimulatory effect of endogenous estrogens on t